IMPACT OF PSORIATIC ARTHRITIS MANIFESTATIONS ON PERCEPTION OF PAIN IMPROVEMENT: POOLED ANALYSIS OF TWO PHASE 3, RANDOMIZED, DOUBLEBLIND, PLACEBO-CONTROLLED STUDIES WITH GUSELKUMAB

被引：0
|
作者：
Nash, P. [1 ,2 ]
Mcinnes, I. [3 ]
Ritchlin, C. T. [4 ]
Tam, L. S. [5 ]
Soriano, E. [6 ]
Starr, M. [7 ]
Rampakakis, E. [8 ,9 ]
Lavie, F. [10 ]
Shawi, M. [11 ]
Baraliakos, X. [12 ,13 ]
Mease, P. J. [14 ,15 ]
机构：
[1] Griffith Univ, Maroochydore, Australia
[2] Univ Queensland, Rheumatol Res Unit, Maroochydore, Australia
[3] Univ Glasgow, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Scotland
[4] Univ Rochester, Dept Med Allergy Immunol & Rheumatol, Med Ctr, Rochester, NY USA
[5] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China
[6] Hosp Italiano Buenos Aires, Rheumatol, Buenos Aires, Argentina
[7] McGill Univ, Div Rheumatol, Hlth Ctr, Montreal, PQ, Canada
[8] McGill Univ, Dept Pediat, Montreal, PQ, Canada
[9] JSS Med Res Inc, Sci Affairs, Montreal, PQ, Canada
[10] Janssen Cilag Global Med Affairs, Immunol Global Med Affairs, Issy Les Moulineaux, France
[11] Janssen Pharmaceut Co Johnson & Johnson, Immunol Global Med Affairs, Horsham, PA USA
[12] Ruhr Univ Bochum, Rheumazentrum Ruhrgebiet, Herne, Germany
[13] Providence St Joseph Hlth, Swedish Med Ctr, Seattle, WA USA
[14] St Joseph Hlth, Seattle, WA USA
[15] Univ Washington, Rheumatol Res, Seattle, WA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
bDMARD; Pain; Psoriatic arthritis; BIOLOGIC-NAIVE; DOUBLE-BLIND;
D O I：
10.1136/annrheumdis-2023-eular.555
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB1095
引用
收藏
页码：1771 / 1772
页数：2
相关论文
共 50 条
  • [31] Apremilast: pooled safety analysis of three phase 3, randomized, controlled trials in patients with psoriatic arthritis
    Schett, G.
    Mease, P. J.
    Kavanaugh, A.
    Adebajo, A. O.
    Gomez-Reino, J. J.
    Wollenhaupt, J.
    Cutolo, M.
    Lespessailles, E.
    Shah, K.
    Hu, C.
    Stevens, R.
    Edwards, C.
    Birbara, C.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2013, 27 : 6 - 6
  • [32] APREMILAST: POOLED SAFETY ANALYSIS OF THREE PHASE 3, RANDOMIZED, CONTROLLED TRIALS IN PATIENTS WITH PSORIATIC ARTHRITIS
    Mease, P. J.
    Kavanaugh, A.
    Adebajo, A. O.
    Gomez-Reino, J. J.
    Wollenhaupt, J.
    Cutolo, M.
    Schett, G.
    Lespessailles, E.
    Shah, K.
    Hu, C.
    Stevens, R.
    Edwards, C. J.
    Birbara, C. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 685 - 685
  • [33] Secukinumab efficacy on resolution of enthesitis in psoriatic arthritis: pooled analysis of two phase 3 studies
    Laura C. Coates
    Johan K. Wallman
    Dennis McGonagle
    Georg A. Schett
    Iain B. McInnes
    Philip J. Mease
    Lawrence Rasouliyan
    Erhard Quebe-Fehling
    Darren L. Asquith
    Andreas E. R. Fasth
    Luminita Pricop
    Corine Gaillez
    Arthritis Research & Therapy, 21
  • [34] Secukinumab efficacy on resolution of enthesitis in psoriatic arthritis: pooled analysis of two phase 3 studies
    Coates, Laura C.
    Wallman, Johan K.
    McGonagle, Dennis
    Schett, Georg A.
    McInnes, Iain B.
    Mease, Philip J.
    Rasouliyan, Lawrence
    Quebe-Fehling, Erhard
    Asquith, Darren L.
    Fasth, Andreas E. R.
    Pricop, Luminita
    Gaillez, Corine
    ARTHRITIS RESEARCH & THERAPY, 2019, 21 (01)
  • [35] Validation of the PROMIS-29 Profile in Patients with Active Psoriatic Arthritis Using Data from a Phase 3, Randomized, Placebo-Controlled Study Evaluating Guselkumab (TREMFYA®)
    Orbai, Ana-Maria
    Coates, Laura
    Deodhar, Atul
    Ritchlin, Christopher
    Kollmeier, Alexa
    Neuhold, Marlies
    Liu, Yi-Hsuan
    Liu, Yan
    Han, Chenglong
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2766 - 2769
  • [36] Guselkumab Improves Anemia in Patients with Active Psoriatic Arthritis: Results From Two Phase 3 Randomized Controlled Clinical Trials
    Kavanaugh, Arthur
    Liu, Yang
    Rahman, Proton
    Mease, Philip
    Gossec, Laure
    Xu, Lillian
    Hsia, Elizabeth
    Shawi, May
    Han, Chenglong
    Neuhold, Marlies
    Deodhar, Atul
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (07) : 788 - 789
  • [37] Bimekizumab Treatment Results in Improvements in Fatigue and Pain in Biologic DMARD-Naive or TNFi-IR Patients with Active Psoriatic Arthritis: Pooled 16-Week Results from Two Phase 3 Randomized, Placebo-Controlled Studies
    Husni, M. Elaine
    Mease, Philip J.
    Merola, Joseph
    Behrens, Frank
    Favalli, Ennio Giulio
    McGonagle, Dennis
    Tillett, William
    Tsuji, Shigeyoshi
    Ink, Barbara
    Assudani, Deepak
    Bajracharya, Rajan
    Coarse, Jason
    Lambert, Jeremy
    Gossec, Laure
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 4197 - 4199
  • [38] Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study
    Deodhar, Atul
    Gottlieb, Alice B.
    Boehncke, Wolf-Henning
    Dong, Bin
    Wang, Yuhua
    Zhuang, Yanli
    Barchuk, William
    Xu, Xie L.
    Hsia, Elizabeth C.
    LANCET, 2018, 391 (10136): : 2213 - 2224
  • [39] Guselkumab Shows Similar Domain-Specific Efficacy in Females and Males with Active Psoriatic Arthritis: Post Hoc Analyses of Three Phase 3, Randomized, Double-blind, Placebo-Controlled Studies
    Eder, Lihi
    Selmi, Carlo
    Mease, Philip
    Ogdie, Alexis
    Nantel, Francois
    Lavie, Frederic
    Sharaf, Mohamed
    Adelakun, Oyediran
    Rampakakis, Emmanouil
    Vegas, Laura Pina
    Coates, Laura
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4720 - 4722
  • [40] Efficacy of Omalizumab in Reducing Asthma Exacerbation in Asian Patients: A Pooled Analysis of Two Randomized Placebo-Controlled Studies
    Huang, M.
    Li, J.
    Liu, S.
    Zhong, N.
    Yang, J.
    Wang, L.
    Sumi, K.
    Lau, X.
    Fogel, R. B.
    Jaumont, X.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
12345